Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT DIMEGLUMINE Cause Insomnia? 60 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Insomnia have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 6.8% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.

60
Reports of Insomnia with FOSAPREPITANT DIMEGLUMINE
6.8%
of all FOSAPREPITANT DIMEGLUMINE reports
38
Deaths
49
Hospitalizations

How Dangerous Is Insomnia From FOSAPREPITANT DIMEGLUMINE?

Of the 60 reports, 38 (63.3%) resulted in death, 49 (81.7%) required hospitalization, and 34 (56.7%) were considered life-threatening.

Is Insomnia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 60 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?

Dyspnoea (142) Pyrexia (136) Nausea (130) Infusion related reaction (83) Diarrhoea (80) Vomiting (71) Rash (66) Hypersensitivity (65) Stomatitis (64) Decreased appetite (62)

What Other Drugs Cause Insomnia?

ADALIMUMAB (6,888) DULOXETINE (5,270) ETANERCEPT (4,983) PREGABALIN (4,882) METHOTREXATE (4,757) LEVOTHYROXINE (4,663) TOCILIZUMAB (4,001) PREDNISONE (3,804) LENALIDOMIDE (3,651) RITUXIMAB (3,637)

Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Insomnia Risk?

FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT DIMEGLUMINE vs FOSCARNET FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL

Related Pages

FOSAPREPITANT DIMEGLUMINE Full Profile All Insomnia Reports All Drugs Causing Insomnia FOSAPREPITANT DIMEGLUMINE Demographics